programme of research

University of York

2005/6


YCR Cancer Research Unit
Director: Professor N J Maitland

V. Dussupt
K. Tiemann
S. Swift
N.J. Maitland
Retargeting of baculoviral gene therapy vectors to infect the prostate.

J.E. Burns
E. Hernandez-Ramon
H. Walker
N.J. Maitland
Structure and functional studies of Human Papilllomavirus E2 proteins.

A.T. Collins
P. Berry
K. Hyde
C. Brinham
N.J. Maitland
Identification of cancer stem cells in human prostate tumours.

A.T. Collins
P. Berry
N.J. Maitland
The Role of Androgen Signalling in the Regulation of Human Prostate Epithelial Stem Cell Differentiation.

S.D Bryce
A.T. Collins
N.J. Maitland
Microarray genotyping and phenotyping of Prostate Cancer Stem Cells.

R.M. Sharrard
J. Spalton
N.J. Maitland
Alterations in the activation pathway of Protein Kinase B in the progression to metastasis of human prostate cancer.


Yorkshire Cancer Research p53 Research Group
Director of Unit: Professor J. Milner

S.U. Ahmed
J. Milner
Selective targetting of cancer cells.

R.E. Adamson
S.J. Allison
J. Milner
The effect of phosphorylated p53 on site-specific histone H3 modifications.

S.J. Allison
J. Milner
Remodelling chromatin on a global scale: a novel protective function of p53.

J.R. Ford
J. Milner
P53: stress versus non-stress regulation.

M. Jiang
J. Milner
RNAi and apoptotic pathways.

M.Jiang
D. Kidd
J. Milner
HPV and human cervical cancer.

C. Lynch
J. Milner
Effects of p53 gene dosage upon the DNA damage response.

C.P. Rubbi
J. Milner
P53 and DNA repair.

L.J. Warnock
S.A. Raines
J. Milner
P53 protein: structures and modifications.